PR Newswire HONG KONG, Dec. 8, 2025 - ASC30 once-daily tablets showed statistically significant and clinically meaningful dose-dependent placebo-adjusted mean body weight reductions with no observed plateau for weight loss. - ASC30 ...
PR Newswire SAN FRANCISCO and SUZHOU, China, Oct. 26, 2025 SAN FRANCISCO and SUZHOU, China, Oct. 26, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, ...
PR Newswire NORTH PALM BEACH, Fla., Aug. 9, 2025 In a recent video Q&A, board-certified plastic surgeon Dr. Pane breaks down the differences between tummy tuck, revision surgery, and liposuction, helping patients choose the right path after ...
PR Newswire CHICAGO, June 22, 2025 Once-weekly medication results in weight loss of up to 22.7% in adults without diabetes and 15.7% in those with type 2 diabetes CHICAGO, June 22, 2025 /PRNewswire/ -- Findings from two studies ...
PR Newswire SAN DIEGO, June 5, 2025 It's Time for Sustainable Habit Changes SAN DIEGO, June 5, 2025 /PRNewswire/ -- The emergence of GLP-1 medications in recent years has presented a promising option for many people who are struggling ...
PR Newswire WAYNE, N.J., May 12, 2025 WAYNE, N.J., May 12, 2025 /PRNewswire/ -- Cosmetic Dermatology & MediSpa of NJ, a leading cosmetic dermatology center in New Jersey (with locations in Englewood, Wayne, and Newark), proudly announces a ...
PR Newswire INDIANAPOLIS, May 11, 2025 Participants achieved an average weight loss of 20.2% with Zepbound vs. 13.7% with Wegovy In key secondary endpoints, Zepbound was superior to Wegovy across all weight reduction targets and waist ...
PR Newswire NEW YORK, April 15, 2025 Headline Summary: Developed by founder Bracha L. Banayan, NP, The DROP Method is the first patient-centered framework that empowers GLP-1 users to take control of their health, behaviors, and long-term ...
PR Newswire MIAMI, March 15, 2025 YupMD.com, a premier telehealth platform, is transforming the weight loss industry by providing convenient, science-backed solutions for individuals seeking sustainable and effective results. Through its ...
PR Newswire SAN DIEGO, March 4, 2025 BL-001 achieved statistically significant placebo-adjusted mean weight loss at 28 days in overweight subjects Overweight individuals in highest dose group experiencing weight loss at day 28 continued ...
Despite many teenagers having irregular diet, parents infrequently offer teens specific healthy eating guidance during holiday season.
Obesity could speed up the pathology of Alzheimer's disease as signified by blood biomarkers, suggesting prevention by managing weight loss.
Following Mediterranean diet pattern together along with physical activity could help prevent excess weight gain and lower harmful abdominal fat.
Consistent ongoing behavioral assistance such as adaptive and monthly support could be the key to prevent weight regain or treat obesity.
WeDosify helps doctors personalize GLP-1 dosing, reducing side effects and improving long-term weight loss adherence in patients.
MEDINDIA
English
हिन्दी
Español
français
中文